WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung
2006; 7(1): 61
Differences in MAP kinase phosphorylation in response to mechanical strain in asthmatic fibroblasts
2006; 7(1): 68
Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children
2006; 7(1): 67
Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse
2006; 7(1): 65
The role of endothelin-1 in hyperoxia-induced lung injury in mice
2006; 7(1): 45
Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype?
2006; 7(1): 70
Muscarinic receptor signaling in the pathophysiology of asthma and COPD
2006; 7(1): 73
Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations
2006; 7(1): 80
Effects of overexpression of IL-10, IL-12, TGF-β and IL-4 on allergen induced change in bronchial responsiveness
2006; 7(1): 72
Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages
2006; 7(1): 66
Markers of exacerbation severity in chronic obstructive pulmonary disease
2006; 7(1): 74
Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis
2006; 7(1): 75
Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis
2006; 7(1): 36
Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons
2006; 7(1): 77
Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro
2006; 7(1): 35
Prenatal and postnatal tobacco smoke exposure and respiratory health in Russian children
2006; 7(1): 48
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation
2006; 7(1): 42
Apoptosis of viral-infected airway epithelial cells limit viral production and is altered by corticosteroid exposure
2006; 7(1): 78
Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D
2006; 7(1): 85
Long-term clearance from small airways in subjects with ciliary dysfunction
2006; 7(1): 79
CpG DNA modulates interleukin 1β-induced interleukin-8 expression in human bronchial epithelial (16HBE14o-) cells
2006; 7(1): 84
Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran
2006; 7(1): 86
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema
2006; 7(1): 53
Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway
2006; 7(1): 60
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire
2006; 7(1): 62
Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers
2006; 7(1): 54
Marked stem cell factor expression in the airways of lung transplant recipients
2006; 7(1): 90
RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis
2006; 7(1): 88
Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study
2006; 7(1): 76
Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test
2006; 7(1): 56
Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD
2006; 7(1): 69
Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
2006; 7(1): 82
Hypoxic vasoconstriction of partial muscular intra-acinar pulmonary arteries in murine precision cut lung slices
2006; 7(1): 93
Spinal afferent neurons projecting to the rat lung and pleura express acid sensitive channels
2006; 7(1): 96
Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis
2006; 7(1): 87
Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells
2006; 7(1): 98
Lung epithelium as a sentinel and effector system in pneumonia – molecular mechanisms of pathogen recognition and signal transduction
2006; 7(1): 97
Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection
2006; 7(1): 71
Pre-natal and post-natal exposure to respiratory infection and atopic diseases development: a historical cohort study
2006; 7(1): 81
Reference values for exhaled nitric oxide (reveno) study
2006; 7(1): 94
Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis
2006; 7(1): 83
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis
2006; 7(1): 95
Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia
2006; 7(1): 99
Decorin and TGF-β1 polymorphisms and development of COPD in a general population
2006; 7(1): 89
The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations
2006; 7(1): 91
Human bronchial fibroblasts express the 5-lipoxygenase pathway
2006; 7(1): 102
IgE sensitisation in relation to flow-independent nitric oxide exchange parameters
2006; 7(1): 92
Cysteinyl-leukotrienes in the regulation of β2-adrenoceptor function: an in vitro model of asthma
2006; 7(1): 103
Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia
2006; 7(1): 100
Laminin-332 alters connexin profile, dye coupling and intercellular Ca2+ waves in ciliated tracheal epithelial cells
2006; 7(1): 105
Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation
2006; 7(1): 113
Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity
2006; 7(1): 109
Magnetic resonance lung function – a breakthrough for lung imaging and functional assessment? A phantom study and clinical trial
2006; 7(1): 106
Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes
2006; 7(1): 104
Exposure of neonates to Respiratory Syncytial Virus is critical in determining subsequent airway response in adults
2006; 7(1): 107
Caveolin-1 and -2 in airway epithelium: expression and in situ association as detected by FRET-CLSM
2006; 7(1): 108
Microarray identifies ADAM family members as key responders to TGF-β1 in alveolar epithelial cells
2006; 7(1): 114
Inhaled steroid/long-acting β2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients
2006; 7(1): 110
Participation of the PI-3K/Akt-NF-κB signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells
2006; 7(1): 101
Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline
2006; 7(1): 112
An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study
2006; 7(1): 116
Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells
2006; 7(1): 115
A key role for STIM1 in store operated calcium channel activation in airway smooth muscle
2006; 7(1): 119
Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction
2006; 7(1): 121
Tuberculosis chemotherapy: current drug delivery approaches
2006; 7(1): 118
Regional differences in the pattern of airway remodeling following chronic allergen exposure in mice
2006; 7(1): 120
Pharmacology of airways and vessels in lung slices in situ: role of endogenous dilator hormones
2006; 7(1): 111
Airway smooth muscle as a target of asthma therapy: history and new directions
2006; 7(1): 123
Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis
2006; 7(1): 122
Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione
2006; 7(1): 124
Role of TNFα in pulmonary pathophysiology
2006; 7(1): 125
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
2006; 7(1): 126
The genetics of chronic obstructive pulmonary disease
2006; 7(1): 130
Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study
2006; 7(1): 127
Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
2006; 7(1): 128
Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease
2006; 7(1): 133
Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells
2006; 7(1): 132
Allergens induce enhanced bronchoconstriction and leukotriene production in C5 deficient mice
2006; 7(1): 129
IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?
2006; 7(1): 135
A self-rating scale for patient-perceived side effects of inhaled corticosteroids
2006; 7(1): 131
Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
2006; 7(1): 134
Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study
2006; 7(1): 136
Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury
2006; 7(1): 137
The pulmonary effects of intravenous adenosine in asthmatic subjects
2006; 7(1): 139
Airway inflammation contributes to health status in COPD: a cross-sectional study
2006; 7(1): 140
Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis
2006; 7(1): 138
Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort
2006; 7(1): 142
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study
2006; 7(1): 141
Neutrophil cannibalism – a back up when the macrophage clearance system is insufficient
2006; 7(1): 143
Hypoxia and dehydroepiandrosterone in old age: a mouse survival study
2006; 7(1): 144
Following damage, the majority of bone marrow-derived airway cells express an epithelial marker
2006; 7(1): 145
Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperresponsiveness and inflammation
2006; 7(1): 146
Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis
2006; 7(1): 147
Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study
2007; 8(1): 2
Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an α-smooth muscle actin-Cre transgenic mouse
2007; 8(1): 1
The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model
2007; 8(1): 3
Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus
2007; 8(1): 6
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
2007; 8(1): 5
Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice
2007; 8(1): 8
Body composition and functional limitation in COPD
2007; 8(1): 7
Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D
2007; 8(1): 9
Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
2007; 8(1): 4
An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre
2007; 8(1): 11
Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age
2007; 8(1): 12
Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis
2007; 8(1): 10
Expression of Toll-like Receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis
2007; 8(1): 17
Reference values of Forced Expiratory Volumes and pulmonary flows in 3–6 year children: a cross-sectional study
2007; 8(1): 14
Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation
2007; 8(1): 16
Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model
2007; 8(1): 13
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials
2007; 8(1): 19
Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
2007; 8(1): 18
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
2007; 8(1): 15
Does respiratory health contribute to the effects of long-term air pollution exposure on cardiovascular mortality?
2007; 8(1): 20
Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD
2007; 8(1): 22
Resolution of LPS-induced airway inflammation and goblet cell hyperplasia is independent of IL-18
2007; 8(1): 24
The role of γδ T cells in airway epithelial injury and bronchial responsiveness after chlorine gas exposure in mice
2007; 8(1): 21
Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts
2007; 8(1): 23
A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease
2007; 8(1): 25
Validation of a guideline-based composite outcome assessment tool for asthma control
2007; 8(1): 26
Stimulation of MAP kinase pathways after maternal IL-1β exposure induces fetal lung fluid absorption in guinea pigs
2007; 8(1): 27
Nitric oxide induces MUC5AC mucin in respiratory epithelial cells through PKC and ERK dependent pathways
2007; 8(1): 28
IL-1β induces murine airway 5-HT2A receptor hyperresponsiveness via a non-transcriptional MAPK-dependent mechanism
2007; 8(1): 29
Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review
2007; 8(1): 30
Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells
2007; 8(1): 31
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
2007; 8(1): 32
Genomic analysis of human lung fibroblasts exposed to vanadium pentoxide to identify candidate genes for occupational bronchitis
2007; 8(1): 34
An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
2002; 3(Suppl 1): S34
Asthma: a major pediatric health issue
2002; 3(Suppl 1): S3
Immunoprophylaxis of respiratory syncytial virus: global experience
2002; 3(Suppl 1): S26
Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link
2002; 3(Suppl 1): S21
Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease
2002; 3(Suppl 1): S8
Potential therapeutic implications of new insights into respiratory syncytial virus disease
2002; 3(Suppl 1): S15
Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
2002; 3(Suppl 1): S40
Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
2002; 3(Suppl 1): S1
In-vivo kinetics of inhaled 5-Aminolevulinic acid-Induced Protoporphyrin IX fluorescence in bronchial tissue
2007; 8(1): 33
Anti-inflammatory properties of desipramine and fluoxetine
2007; 8(1): 35
Alterations in cytoskeletal and immune function-related proteome profiles in whole rat lung following intratracheal instillation of heparin
2007; 8(1): 36
Antisense oligonucleotide inhibition of Heat Shock Protein (HSP) 47 improves bleomycin-induced pulmonary fibrosis in rats
2007; 8(1): 37